ITGR · Integer Holdings Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · ITGR

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$1.85B	$1.72B	$1.60B	$1.38B	$1.22B	$1.07B
Cost of Revenue	$1.35B	$1.26B	$1.18B	$1.02B	$884.11M	$787.74M
Gross Profit	$500.39M	$459.01M	$418.29M	$359.01M	$336.97M	$285.71M
R&D	$49.50M	$53.42M	$63.77M	$60.92M	$51.98M	$48.47M
SG&A	$211.75M	$185.20M	$175.62M	$160.58M	$141.42M	$109.01M
Total Operating Expenses	$279.12M	$250.78M	$250.96M	$237.68M	$201.26M	$165.09M
D&A	$130.67M	$111.03M	$98.84M	$91.99M	$81.37M	$79.32M
Operating Income	$221.26M	$208.24M	$167.33M	$121.33M	$135.71M	$120.61M
Interest Expense	$43.21M	$56.37M	$53.37M	$38.63M	$31.63M	$38.22M
Income Tax	$22.57M	$26.51M	$16.64M	$10.61M	$8.04M	$8.95M
Net Income	$102.81M	$119.90M	$90.65M	$66.38M	$96.81M	$77.26M
EPS - Basic	$2.96	$3.57	$2.72	$2.00	$2.93	$2.35
EPS - Diluted	$2.89	$3.36	$2.69	$1.99	$2.91	$2.33

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$17.16M	$46.54M	$23.67M	$24.27M	$17.89M	$49.21M
Accounts Receivable	$346.08M	$245.27M	$238.28M	$224.32M	$182.31M	$156.21M
Inventory	$253.74M	$247.13M	$239.72M	$208.77M	$155.70M	$149.32M
Accounts Payable	$113.13M	$101.50M	$120.29M	$110.78M	$76.86M	$51.57M
Current Assets	$770.10M	$671.12M	$617.67M	$558.30M	$452.98M	$412.94M
Total Assets	$3.41B	$3.08B	$2.94B	$2.79B	$2.58B	$2.37B
Current Liabilities	$232.04M	$227.17M	$220.97M	$223.75M	$159.63M	$156.19M
Long-term Debt	$1.19B	$980.15M	$959.92M	$907.07M	$812.88M	$693.76M
Total Liabilities	$1.66B	$1.46B	$1.42B	$1.38B	$1.23B	$1.10B
Stockholders' Equity	$1.75B	$1.62B	$1.52B	$1.42B	$1.35B	$1.27B
Retained Earnings	$994.05M	$891.25M	$771.35M	$680.70M	$614.32M	$517.52M

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$196.15M	$205.21M	$180.21M	$116.38M	$156.67M	$181.34M
Investing Cash Flow	($270.73M)	($195.41M)	($163.37M)	($200.42M)	($271.00M)	($56.58M)
Financing Cash Flow	$43.56M	$13.32M	($18.01M)	$92.48M	$81.99M	($88.58M)
CapEx	$91.03M	$105.36M	$119.94M	$74.73M	$53.46M	$46.83M
Free Cash Flow	$105.12M	$99.85M	$60.27M	$41.65M	$103.20M	$134.51M

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	27.0%	26.7%	26.2%	26.1%	27.6%	26.6%
Operating margin	11.9%	12.1%	10.5%	8.8%	11.1%	11.2%
EBITDA margin	19.0%	18.6%	16.7%	15.5%	17.8%	18.6%
Net margin	5.5%	7.0%	5.7%	4.8%	7.9%	7.2%
Free cash flow margin	5.7%	5.8%	3.8%	3.0%	8.5%	12.5%
FCF / Net income	1.02	0.83	0.66	0.63	1.07	1.74
R&D / Revenue	2.7%	3.1%	4.0%	4.4%	4.3%	4.5%
SG&A / Revenue	11.4%	10.8%	11.0%	11.7%	11.6%	10.2%
Effective tax rate	18.0%	18.1%	15.5%	13.8%	7.7%	10.4%
Return on assets	3.0%	3.9%	3.1%	2.4%	3.7%	3.3%
Return on equity	5.9%	7.4%	6.0%	4.7%	7.1%	6.1%
Return on invested capital	6.2%	6.6%	5.7%	4.5%	5.8%	5.5%
Liquidity
Current ratio	3.32	2.95	2.80	2.50	2.84	2.64
Quick ratio	2.23	1.87	1.71	1.56	1.86	1.69
Cash ratio	0.07	0.20	0.11	0.11	0.11	0.32
Leverage
Debt / Equity	0.68	0.61	0.63	0.64	0.60	0.55
Debt / Assets	0.35	0.32	0.33	0.32	0.31	0.29
Debt / EBITDA	3.37	3.07	3.61	4.25	3.74	3.47
Interest coverage	5.1x	3.7x	3.1x	3.1x	4.3x	3.2x
Equity multiplier	1.95	1.90	1.94	1.97	1.91	1.87
Liabilities / Assets	0.49	0.47	0.48	0.49	0.48	0.46
Efficiency
Asset turnover	0.54	0.56	0.54	0.49	0.47	0.45
Inventory turnover	5.33	5.09	4.92	4.87	5.68	5.28
Days sales outstanding	68d	52d	54d	60d	54d	53d
Days inventory outstanding	68d	72d	74d	75d	64d	69d
Days payable outstanding	31d	29d	37d	40d	32d	24d
Cash conversion cycle	106d	94d	91d	95d	87d	98d
Valuation
P / E	27.1x	39.4x	36.8x	34.4x	29.4x	34.8x
P / B	1.6x	2.9x	2.2x	1.6x	2.1x	2.1x
P / S	1.5x	2.8x	2.1x	1.7x	2.3x	2.5x
EV / EBITDA	11.3x	17.7x	16.1x	14.8x	16.8x	16.7x
Growth
Revenue growth (YoY)	8.0%	7.5%	16.0%	12.7%	13.8%	-14.7%
Revenue CAGR (3y)	10.4%	12.0%	14.2%	3.0%	0.2%	-9.8%
Revenue CAGR (5y)	11.5%	6.4%	5.6%	-1.2%	-2.5%	6.0%
Gross profit growth (YoY)	9.0%	9.7%	16.5%	6.5%	17.9%	-19.5%
Operating income growth (YoY)	6.3%	24.4%	37.9%	-10.6%	12.5%	-23.5%
Net income growth (YoY)	-14.3%	32.3%	36.6%	-31.4%	25.3%	-19.8%
EPS growth (YoY)	-14.0%	24.9%	35.2%	-31.6%	24.9%	-20.2%
EPS CAGR (3y)	13.2%	4.9%	4.9%	-12.0%	-17.3%	3.7%
EPS CAGR (5y)	4.4%	2.8%	-12.2%	-1.0%	72.6%	-
FCF growth (YoY)	5.3%	65.7%	44.7%	-59.6%	-23.3%	14.8%
FCF CAGR (5y)	-4.8%	-3.1%	-13.2%	-16.4%	17.1%	-
Book value growth (YoY)	7.9%	6.6%	7.2%	4.6%	6.6%	10.3%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$1.85B total

Reportable Segment$1.85B · 100.0%

Product / service

$1.85B total

Cardio And Vascular$1.11B · 59.7%

Cardiac Rhythm Management Neuromodulation$668.80M · 36.1%

Other Markets$77.75M · 4.2%

Geographic

$1.85B total

US$979.81M · 52.9%

Rest Of World$469.88M · 25.3%

CR$173.52M · 9.4%

PR$131.26M · 7.1%

IE$99.16M · 5.3%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

1.54

Grey zone

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

6/9

Neutral

✓Net income positive
✓Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
✗Long-term debt decreased
✓Current ratio improved
✓No share dilution
✓Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Electromedical & Electrotherapeutic Apparatus

Company	Revenue (last FY)	Net margin	ROE
BLFS	-	-	-1.2%
OM	$119.48M	-68.3%	-64.3%
TMDX	$605.49M	31.4%	40.2%
MDT	-	-	-
CNMD	$1.37B	3.4%	4.6%

Comparing Integer Holdings Corp against the 5 most active filers in the same SIC group.